Gold nanoparticle-siRNA mediated oncogene knockdown at RNA and protein level, with associated gene effects

Hannah Winifred Child, Yulán Hernandez, João Conde, Margaret Mullin, Pedro Baptista, Jesus Maria De La Fuente, Catherine Cecilia Berry

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

13 Citas (Scopus)

Resumen

Aims: RNAi is a powerful tool for gene silencing that can be used to reduce undesirable overexpression of oncogenes as a novel form of cancer treatment. However, when using RNAi as a therapeutic tool there is potential for associated gene effects. This study aimed to utilize gold nanoparticles to deliver siRNA into HeLa cells. Results: Knockdown of the c-myc oncogene by RNAi, at the RNA, protein and cell proliferation level was achieved, while also identifying associated gene responses. Discussion: The gold nanoparticles used in this study present an excellent delivery platform for siRNA, but do note associated gene changes. Conclusion: The study highlights the need to more widely assess the cell physiological response to RNAi treatment, rather than focus on the immediate RNA levels.

Idioma originalInglés
Páginas (desde-hasta)2513-2525
Número de páginas13
PublicaciónNanomedicine
Volumen10
N.º16
DOI
EstadoPublicada - 1 ago. 2015
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Gold nanoparticle-siRNA mediated oncogene knockdown at RNA and protein level, with associated gene effects'. En conjunto forman una huella única.

Citar esto